Latest Regulatory News

Island Pharmaceuticals has partnered with the Burnet Institute to explore new antiviral applications for its lead drugs, targeting measles, chikungunya, and Ross River virus. This collaboration leverages existing data and government funding to enhance the company’s clinical pipeline without major capital outlay.

Toubani Resources has given the green light to its Kobada Gold Project in Mali, marking a significant milestone with construction now underway and first gold production targeted for late 2027.

Pengana International Equities has dismissed an unauthorized announcement about management changes and outlined plans for a shareholder buy-back and potential special dividend amid its strategic review.

Star Minerals has obtained the crucial Native Vegetation Clearing Permit, completing all regulatory approvals to commence mining at the Tumblegum South Gold Project in Western Australia.

South Harz Potash Limited has raised A$1.25 million to fund exploration at its newly licensed copper-gold projects in Sweden, signalling a strategic pivot towards critical minerals and a planned rebrand to Turnstone Resources.

The South Australian Court of Appeal has overturned a 2023 government proclamation, returning the Bird in Hand Gold deposit to Terramin’s exploration licence and reshaping the company’s exploration prospects.

Rhythm Biosciences has achieved a significant regulatory milestone with NATA accreditation for its ColoSTAT® blood-based colorectal cancer test, enabling its commercial rollout in Australia and strengthening reimbursement prospects.

Pan African Resources has agreed to acquire Emmerson Resources via a scheme of arrangement valued at approximately A$311 million, offering Emmerson shareholders a 36.4% premium. The deal aligns interests in the Tennant Creek Joint Venture and provides exposure to a larger gold producer.

MyState Limited has confirmed a fully franked ordinary dividend of 12 cents per share for the half-year ending December 2025, alongside an updated dividend reinvestment plan price reflecting recent trading activity.

Dyno Nobel has signed a binding agreement to sell its Phosphate Hill fertiliser business to Mayfair Australia Corporation, marking a strategic pivot to focus solely on its explosives operations. The deal, expected to complete in Q3 FY26, includes deferred payments and regulatory conditions.

Native Mineral Resources has reported impressive shallow high-grade gold intercepts at its Podosky deposit, reinforcing plans to commence mining by April 2026. The results bolster confidence in the deposit’s open-pit potential and support ongoing development at the Ravenswood Gold Project.

A new clinical study from Sichuan University confirms that TruScreen’s AI-enabled cervical cancer screening combined with high-risk HPV testing outperforms traditional cytology methods, reinforcing its global potential.